anti-Protease, serine, 50 (PRSS50) Antibodies

May be involved in proteolysis through its threonine endopeptidase activity (By similarity).. Additionally we are shipping Protease, serine, 50 Kits (7) and Protease, serine, 50 Proteins (6) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
PRSS50 235631 Q8BLH5
PRSS50 29122 Q9UI38
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-Protease, serine, 50 Antibodies at

Showing 10 out of 32 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated ELISA, WB   200 μL Log in to see 16 Days
Human Mouse Un-conjugated ELISA Detection limit for recombinant GST tagged TSP50 is 0.3 ng/ml as a capture antibody. 100 μg Log in to see 11 to 12 Days
Human Mouse Un-conjugated WB Western Blot analysis of TSP50 expression in transfected 293T cell line ( H00029122-T01 ) by TSP50 MaxPab polyclonal antibody.  Lane 1: TSP50 transfected lysate(42.35 KDa). Lane 2: Non-transfected lysate. 50 μg Log in to see 11 to 12 Days
Mouse Rat Un-conjugated WB   0.1 mg Log in to see 8 to 11 Days
Human Rabbit Un-conjugated IHC, IHC (p)   0.1 mL Log in to see 10 to 13 Days
Human Rabbit Un-conjugated IHC, WB   100 μL Log in to see 7 to 9 Days
Human Rabbit Un-conjugated IF (p), IHC (p), WB   100 μL Log in to see 3 to 7 Days
Human Rabbit Un-conjugated EIA, IHC (fro), WB   0.2 mL Log in to see 6 to 8 Days
Mouse Rat Alexa Fluor 647 WB   0.1 mL Log in to see 10 to 13 Days
Mouse Rat DyLight 755 WB   0.1 mL Log in to see 10 to 13 Days

PRSS50 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) ,
, , , , , , , , , , , ,
Human , , ,
Rat (Rattus) ,

More Antibodies against Protease, serine, 50 Interaction Partners

Mouse (Murine) Protease, serine, 50 (PRSS50) interaction partners

  1. findings indicate that BORIS (show CTCFL Antibodies)-induced expression of TSP50 is governed by accessibility and binding of BORIS (show CTCFL Antibodies) to the promoter

  2. TSP50 promotes cell proliferation, at least partially, through activation of the NF-kappaB (show NFKB1 Antibodies) signalling pathway.

  3. results showed that downregulation of TSP50 expression in P19 embryonal carcinoma stem cells not only reduced cell proliferation, colony formation, and migration but also induced cell apoptosis

  4. TSP50 may perform a critical biologic function in mammalian spermatogenesis. It may be a new type of threonine protease whose linear catalytic structure is similar to many serine proteases, except f (show TRH Antibodies)or a Thr (show SIGLEC1 Antibodies)-for-Ser residual catalytic site substitution.

  5. These findings suggested that DNA methylation (show HELLS Antibodies) might regulate the TSP50 and mTSP50 gene expressions in different types of tissues and spermatic cells.

Human Protease, serine, 50 (PRSS50) interaction partners

  1. TSP50 promotes the proliferation, migration and invasion of gastric cancer cells involving NF-kappaB (show NFKB1 Antibodies) dependent EMT (show ITK Antibodies) activation. Targeting TSP50 may provide a novel therapeutic strategy for the management of gastric cancer

  2. human epidermal growth factor receptor (show EGFR Antibodies) 2 (HER-2 (show ERBB2 Antibodies)) levels, were correlated well with TSP50/p-Samd2 (show SARM1 Antibodies)/3 and TSP50/p27 (show PAK2 Antibodies) expression status. Thus, our studies revealed a novel regulatory mechanism underlying TSP50-induced cell proliferation and provided a new favorable intervention target for the treatment of breast cancer

  3. In patients with Colon cancer, the expression of TSP50 gene was associated with a poor prognosis.

  4. TSP50 plays a significant role in NSCLC cell proliferation and may act as a novel oncogene (show RAB1A Antibodies) in the development and progression of NSCLC.

  5. Results suggest that 7P3A, which consists of 70 % 25-methoxyl-dammarane-3beta, 12beta, 20-triol and 30 % artemisinin, exhibits anti-cancer effects, in part, through downregulation of testes-specific protease 50 (TSP50) expression.

  6. Results show that TSP50 is up-regulated in laryngocarcinoma tumour tissues and its down-regulation inhibits cell proliferation, reduces cell migration and induces cell apoptosis of laryngocarcinoma in NF-KB mediated pathway.

  7. we found that some breast cancer diagnosis-associated features such as tumor size, tumor grade, estrogen receptors (ER) and progesterone receptors (PR) levels, were correlated well with TSP50/p65 (show GORASP1 Antibodies) and TSP50/MMP9 (show MMP9 Antibodies) expression status

  8. TSP50's threonine protease activity is crucial for its effects on tumor formation.

  9. The mutations in the catalytic triad of TSP50 could significantly depressed TSP50-mediated cell proliferation and tumor formation.

  10. High TSP50 expression is associated with laryngocarcinoma.

Protease, serine, 50 (PRSS50) Antigen Profile

Protein Summary

May be involved in proteolysis through its threonine endopeptidase activity (By similarity).

Gene names and symbols associated with PRSS50

  • protease, serine 50 (Prss50) antibody
  • protease, serine 50 (PRSS50) antibody
  • 79H19C antibody
  • CT20 antibody
  • TSP50 antibody

Protein level used designations for PRSS50

probable threonine protease PRSS50 , serine protease 50 , testes-specific protease 50 , testis-specific protease-like protein 50 , cancer/testis antigen 20 , testes specific protease 50

235631 Mus musculus
29122 Homo sapiens
Selected quality suppliers for anti-Protease, serine, 50 (PRSS50) Antibodies
Did you look for something else?